MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET

Y-Q Li(Sun Yat-sen University), Jun Ma(Shanghai Institute of Technology)

Cell Death and Disease

January 22, 2015

10.1038/cddis.2014.582

Cited by 57

Related Papers

Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

|New England Journal of Medicine|2019|934

A Metagenomic Approach to Characterization of the Vaginal Microbiome Signature in Pregnancy

|PLoS ONE|2012|703

Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma

|Cell Research|2020|483

Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3

|Cancer Research|2019|423

Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

|The Lancet|2021|234